TY  - JOUR
AU  - Orozco, Carlos A
AU  - Martinez-Bosch, Neus
AU  - Guerrero, Pedro E
AU  - Vinaixa, Judith
AU  - Dalotto-Moreno, Tomás
AU  - Iglesias, Mar
AU  - Moreno, Mireia
AU  - Djurec, Magdolna
AU  - Poirier, Françoise
AU  - Gabius, Hans-Joachim
AU  - Fernandez-Zapico, Martin E
AU  - Hwang, Rosa F
AU  - Guerra, Carmen
AU  - Rabinovich, Gabriel A
AU  - Navarro, Pilar
PY  - 2018
DO  - 10.1073/pnas.1722434115
SN  - 0027-8424
UR  - http://hdl.handle.net/20.500.12105/8359
AB  - Pancreatic ductal adenocarcinoma (PDA) remains one of the most lethal tumor types, with extremely low survival rates due to late diagnosis and resistance to standard therapies. A more comprehensive understanding of the complexity of PDA pathobiology,...
LA  - eng
PB  - National Academy of Sciences
KW  - Galectin-1
KW  - Pancreatic cancer
KW  - Pancreatic stellate cells
KW  - Tumor immunity
KW  - Tumor microenvironment
KW  - Animals
KW  - Carcinoma, Pancreatic Ductal
KW  - Cell Division
KW  - Cell Movement
KW  - Culture Media, Conditioned
KW  - Galectin 1
KW  - Galectins
KW  - Gene Expression Regulation, Neoplastic
KW  - Gene Knockdown Techniques
KW  - Gene Ontology
KW  - Heterografts
KW  - Humans
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Mice
KW  - Mice, Knockout
KW  - Mice, Transgenic
KW  - Neoplasm Metastasis
KW  - Neovascularization, Pathologic
KW  - Pancreatic Neoplasms
KW  - Pancreatic Stellate Cells
KW  - Paracrine Communication
KW  - RNA, Small Interfering
KW  - Stromal Cells
KW  - Tumor Microenvironment
KW  - Molecular Targeted Therapy
TI  - Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk
TY  - journal article
ER  -